Butterfly Network (BFLY)

The company’s distinguishing technology is its Ultrasound-on-Chip platform. Instead of relying on traditional piezoelectric crystal probes that are typically designed for specific types of scans, Butterfly uses semiconductor-based technology intended to support broad, whole-body imaging from a single probe. The Butterfly iQ+ device combines this hardware with mobile software, cloud connectivity, workflow tools, and educational features designed to help healthcare professionals acquire and interpret ultrasound information.

Butterfly operates at the intersection of medical devices, software, and healthcare data. Its products are used by a range of clinicians, including physicians, nurses, and point-of-care specialists, with potential applications in primary care, emergency medicine, critical care, obstetrics, and procedural guidance. The business model includes device sales as well as software and services that support image storage, collaboration, and fleet management.

As a listed company, Butterfly Network is tied to the broader adoption of point-of-care ultrasound and the willingness of health systems to integrate handheld imaging into routine care. Its opportunity is significant, but it competes with established medical imaging companies and must navigate regulatory, reimbursement, training, and hospital procurement challenges.